IPO Roundup: CoreWeave, Cal Redwood Acquisition and more
Seeking Alpha News (Mon, 10-Mar 10:50 AM ET)
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
Globe Newswire (Fri, 7-Mar 5:30 PM ET)
Wearable medical device company Kestra surges on public debut
Seeking Alpha News (Thu, 6-Mar 12:46 PM ET)
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of March 10, 2025, KMTS stock price climbed to $21.20 with 528,364 million shares trading.
KMTS has a market cap of $1.05 billion. This is considered a Small Cap stock.
KMTS support price is $19.38 and resistance is $22.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.